StreetInsider.com News Articles

CYIOS Corp names John O'Shea as new CEO and chairman

Tue, 02 Dec 2025 08:30:40 -0500

CYIOS Corp. (OTC: CYIO) appointed John O'Shea as chief executive officer and chairman of the board, according to a company statement. O'Shea brings over 30 years of experience in finance, technology and business development to the diversified holding company focused on medical, technology and innovation sectors.

O'Shea previously held senior executive positions at Bendigo Bank and Adelaide Bank, and founded INCH Corp Pty Ltd and Helio Lending. He also served in leadership roles at Hannon Insurance & Superannuation and William M. Mercer, and created educational platforms in collaboration with RMIT University.

Under O'Shea's leadership, CYIOS has begun planning CyioIQ, an AI and

CYIOS Corp names John O'Shea as new CEO and chairman

Tue, 02 Dec 2025 08:30:40 -0500

Under O'Shea's leadership, CYIOS has begun planning CyioIQ, an AI and

CYIOS Corp names John O'Shea as new CEO and chairman

Tue, 02 Dec 2025 08:30:40 -0500

Under O'Shea's leadership, CYIOS has begun planning CyioIQ, an AI and

CYIOS Corp names John O'Shea as new CEO and chairman

Tue, 02 Dec 2025 08:30:40 -0500

Under O'Shea's leadership, CYIOS has begun planning CyioIQ, an AI and

CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation

Tue, 02 Dec 2025 08:30:00 -0500

MELBOURNE, Australia and PALM BEACH, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- CYIOS Corp. (OTC: CYIO), a diversified holding company focused on acquiring, building, and scaling high-growth businesses in the medical, technology, and innovation sectors, is pleased to announce the appointment of John O’Shea as its new Chief Executive Officer and Chairman of the Board.

A serial entrepreneur, published author, and seasoned senior executive with more than 30 years of experience across finance, technology, education, and high-growth venture building, O'Shea steps into the role with a bold vision: to transform CYIOS into a modern, AI-enabled

CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation

Tue, 02 Dec 2025 08:30:00 -0500

CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation

Tue, 02 Dec 2025 08:30:00 -0500

CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation

Tue, 02 Dec 2025 08:30:00 -0500

CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations

Wed, 29 Oct 2025 08:30:00 -0500

MELBOURNE, Australia and PALM BEACH, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation LLC (OTC: CYIO) (“CYIOS” or the “Company”), a Nevada-registered holding company focused on acquisitions, modernization and technology integration in the healthcare and medical supply sectors, today announced it has engaged Atlanta Capital Partners, LLC to lead a renewed investor relations strategy designed to expand CYIOS’s visibility and enhance communication across the investment community.

Atlanta Capital Partners, founded in 2004, is a proactive investor relations and capital markets advisory firm with extensive experience assisting public companies in elevating market awareness, strengthening liquidity,

CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations

Wed, 29 Oct 2025 08:30:00 -0500

CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations

Wed, 29 Oct 2025 08:30:00 -0500

CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations

Wed, 29 Oct 2025 08:30:00 -0500

CYIOS names new leadership, plans AI medical platform development

Tue, 21 Oct 2025 08:32:19 -0500

CYIOS Corporation (OTC: CYIO) announced that David Lewis stepped down from his roles with the company. As part of the transition, Lewis voluntarily returned 16,560 Series D Preferred Shares to CYIOS and canceled outstanding salary and loan obligations.

The company stated it is working with its independent auditor to complete two years of PCAOB-audited financial statements, with 2024 fully completed. CYIOS continues focusing on increasing working capital through strategic investment initiatives aimed at paying down debt obligations of its subsidiary Noir Medical Supplies, with completion expected by mid-2026.

"These are meaningful milestones in strengthening CYIOS' foundation for growth," said John O'Shea, Chairman

CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors

Tue, 21 Oct 2025 08:30:00 -0500

MELBOURNE, Australia and PALM BEACH, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation (OTC: CYIO) today announced that David Lewis has stepped down from his roles with CYIOS, and as part of this transition, he has voluntarily agreed to return 16,560 Series D Preferred Shares to the Company, and cancel all outstanding salary and loan obligations. This decisive step strengthens the company’s balance sheet, simplifies its capital structure, and positions CYIOS for its next stage of growth. We wish David all the best for his next endeavor.

CYIOS is also working closely with its

CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors

Tue, 21 Oct 2025 08:30:00 -0500

CYIOS is also working closely with its

CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors

Tue, 21 Oct 2025 08:30:00 -0500

CYIOS is also working closely with its

CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors

Tue, 21 Oct 2025 08:30:00 -0500

CYIOS is also working closely with its

Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream